Japan, Jan. 28 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEINS.' Other related details are as follows:
Application Number: JP,2025-019929
Category (FI): A61K31/4965,A61K31/513,A61K31/519,A61K31/7088,A61K31/7105,A61K38/21,A61K39/12,A61K39/395@S,A61P31/14,A61P43/00,121,C07K16/10,C12N1/15,C12N1/19,C12N1/21,C12N15/113@Z,C12N15/13,C12N15/63@Z,C12N5/10,C12P21/08
Stage: Grant (IP right document published.)
Filing Date: Feb. 10, 2025
Publication Date: April 17, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....